Sponsor or institution
Clinical trials and research at Aquinnah Pharmaceuticals, INC.
As of November 12, 2026, Find a Trial lists 4 NIH-funded research projects at this institution, with $5.0 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4NIH research projects
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
A new Alzheimer’s treatment targeting tau proteins
A biotech company is testing a new Alzheimer’s therapy aimed at tau protein to slow or stop thinking and memory decline.
-
Oral brain-penetrant therapy for ALS that may slow or reverse progression
A promising new pill designed to reach the brain and slow or reverse ALS progression might help people living with ALS.
-
A new approach to treating Alzheimer's disease by targeting tau protein
This research is developing new medicines to help people with Alzheimer's disease by focusing on a specific protein called tau.
-
Creating a new oral treatment for ALS
This study is testing a new oral medication for people with ALS that aims to help slow down the disease by targeting a harmful protein, which could improve muscle control and make daily life a bit easier.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.